Daniel D. Rhoads

Clinical microbiologist @ClevelandClinic. Interested in novel diagnostics, AMR, phage therapy, ID pathology, biofilm infections, & informatics. (Views are mine)

[Daniel D. Rhoads @danrhoads]

🦠🦠🦠 Subclade K 🦠🦠🦠

Newly published paper from @ClevelandClinic describing the emergence of H3N2 Subclade K in Ohio:

https://t.co/DcTpxg86xY

[Daniel D. Rhoads @danrhoads]

Tiny bacilli seen on sputum Gram stain.

Its growth satellites around S. aureus on blood agar, and it grows well on chocolate 🍫 agar.

Pfieffer mistakenly thought it caused influenza when he discovered it, which is why “influenza” is in its name.

🧫🔬Haemophilus influenzae🔬🧫

[Daniel D. Rhoads @danrhoads]

🔬Classic Gram stain morphology🔬

🕷️Spidery gram-positive bacilli🕷️

Cutibacterium (Propionibacterium) acnes

📸 Pictured is a blood 🩸culture 🧫 that was contaminated with these bacteria from the skin. It can cause infection; C. acnes is a common cause of shoulder PJI.

[Daniel D. Rhoads @danrhoads]

🦠🦠 H3N2 subclade K is here 🦠 🦠

Kudos to the diagnostic microbiology team @CLEClinicLabs for standing up Influenza A whole genome sequencing just in time for the new flu.

https://t.co/i4EDcJIvGI

[Daniel D. Rhoads @danrhoads]

Free rapid AST webinar from @ASMicrobiology on 6 Nov 2025:

https://t.co/kPR8tUcy20

[CCF ID Fellows @ccf_idfellows]

🦠 Second place at #IDWeek2025 #BugBowl but first in our hearts 💙
The CCF Bug Bowl team absolutely crushed it today! Months of hard work, dedication, and infectious enthusiasm paid off — they made us so proud! #IDFellows #TeamCCF @IDWeekmtg

[Daniel D. Rhoads @danrhoads]

Flu A doing its thing…

[Daniel D. Rhoads @danrhoads]

🦠🦠🦠🦠🦠

So much flu…

https://t.co/fCJexf52sY

[Daniel D. Rhoads @danrhoads]

🦠🦠🦠🦠🦠

So much flu…

https://t.co/fCJexf52sY

[CCF ID Fellows @ccf_idfellows]

As we approach World Antimicrobial Awareness Week, at today’s micro plate rounds we learned about beta-lactamases—the enzymes driving beta-lactam resistance. A timely discussion on the mechanisms fueling AMR. #WAAW #AntimicrobialResistance #InfectiousDiseases @PathologyBurns

[Mike Honey @Mike_Honey_]

Here's the latest variant picture for the United States.

DeFLuQE variants are still dominant, but growth has ended and they are in sharp decline.

XEC.* grew strongly to around 27%.
🧵

[CCF ID Fellows @ccf_idfellows]

Micro Plate rounds are always a highlight of the week! So grateful for the teaching and expertise our amazing microbiology team shares with us at CCF . Learning from the best to provide the best care!
@danrhoads @ClevelandClinic

[Daniel D. Rhoads @danrhoads]

https://t.co/zhsR3ckELo

❗️Mycoplasma pneumoniae is BACK 🫁

[🎒Joanna Teglund✊😷🍉Human life is sacred @JoannaTeglund]

This is the 5th year of the pandemic in the Let It Rip Kingdom of Sweden. Everyone is constantly reinfected with the immune damaging SARS-CoV-2.

Respiratory virus/bacteria infections like Rhino/Enterovirus, Adenovirus, Mycoplasma pneumoniae or Pertussis are skyrocketing.

🧵1/

[Ruth Ann Crystal, MD @CatchTheBaby]

Walking pneumonia is a bacterial infection caused by Mycoplasma pneumoniae.

Mycoplasma pneumoniae infections have been increasing in children since last spring and remain high, especially for kids ages 2-4 years, according to the CDC. https://t.co/EtzL7BP6Wj

[Daniel D. Rhoads @danrhoads]

🦠 🧠 Microbial Memory 🧠 🦠

Fun & brief write-up by @madelinerb2 on an understudied and clinically important part of microbiology that impacts small colony variants, mucoid phenotypes, heteroresistance, virulence, and more….

https://t.co/T9NAj1fXmh

@necrosignaling

[Daniel D. Rhoads @danrhoads]

@LinaMengPharmD I love the tables in this Livermore paper:
https://t.co/dwz8IboCSL

I agree this does not make good sense and retesting might be helpful. The cefoxitin resistance is not consistent with an ESBL. The ceftriaxone susceptibility is not consistent with AmpC.

[Daniel D. Rhoads @danrhoads]

I appreciate “Stop being a hero”🦸 from @aliciamckaynz:

https://t.co/wOntJ3EF5h

[Daniel D. Rhoads @danrhoads]

Great insights from @romneyintn

[Clinical Infectious Diseases @CIDJournal]

How New Regulation of Laboratory-Developed Antimicrobial Susceptibility Tests Will Affect Infectious Diseases Clinical Practice

https://t.co/hqTMxbcusK

[Daniel D. Rhoads @danrhoads]

🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠

Flu is still peaking in Cleveland.

https://t.co/fCJexf4uDq

[PARASITOLOGÍA @Parasitologia10]

Strongyloides stercoralis en muestra BK de esputo, coloración de Ziehl Neelsen

[Daniel D. Rhoads @danrhoads]

A thoughtful microbiology commentary by @Linoj_S in @ASMicrobiology @JClinMicro on the @US_FDA proposed LDT rule:

“A rule must also balance the potential negative impact to patient care with realistic safety risks for infectious disease diagnostics.”

https://t.co/1umt61ZZMM